Tepotinib in patients with MET exon 14 skipping NSCLC: Efficacy and safety by line of therapy Meeting Abstract
| Authors: | Griesinger, F.; Felip, E.; Smit, E. F.; Veillon, R.; Raskin, J.; Thomas, M.; Conte, P.; Kowalski, D.; Paz-Ares, L.; Garcia Ledo, G.; de Marinis, F.; Scherz, A.; Berghoff, K.; Bruns, R.; Otto, G.; Paik, P. |
| Abstract Title: | Tepotinib in patients with MET exon 14 skipping NSCLC: Efficacy and safety by line of therapy |
| Meeting Title: | European Lung Cancer Congress (ELCC) 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Mar 30-Apr 2 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-04-01 |
| Start Page: | S40 |
| End Page: | S41 |
| Language: | English |
| ACCESSION: | WOS:000778453100025 |
| DOI: | 10.1016/j.annonc.2022.02.033 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 24P -- Source: Wos |
